Trial of Cabozantinib (XL184) in Non-Small Cell Lung Cancer With Brain Metastases

Clinical trial NCT02132598 · TERMINATED

Trial details

NCT number: NCT02132598
Sponsor: Liza Villaruz, MD
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer (NSCLC)Metastases to the Brain

Start date: 2015-12-01
Primary completion: 2019-08-09
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.